Captopril or prostaglandin E1 ameliorate adverse renal hemodynamic effects of indomethacin in uninephrectomized rats
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 98 (1) , 31-38
- https://doi.org/10.1016/0041-008x(89)90131-2
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Converting enzyme inhibition and progressive glomerulosclerosis in the ratKidney International, 1987
- Reduction of proteinuria by angiotensin converting enzyme inhibitionKidney International, 1987
- The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captoprilToxicology and Applied Pharmacology, 1986
- Prostaglandin and Thromboxane Formation in Glomeruli from Rats with Reduced Renal MassNephron, 1986
- Role of prostaglandins and angiotensin II in experimental glomerulonephritisKidney International, 1985
- Captopril slows the progression of chronic renal disease in partially nephrectomized ratsToxicology and Applied Pharmacology, 1985
- Contribution of the renin-angiotensin system to the control of intrarenal hemodynamicsKidney International, 1984
- Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.Circulation Research, 1982
- Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibitionKidney International, 1981
- Renal effects of drugs that inhibit prostaglandin synthesisKidney International, 1980